Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PediCAP trial of step-down oral antibiotics for children hospitalized with severe pneumonia
ISRCTN63115131Phase 2Completed
- Sponsor
- Penta Foundation
- Start
- Oct 2020
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
01
Overview
Phase 2, randomised, open-label trial of amoxicillin, amoxicillin + clavulanate, benzylpenicillin, gentamicin, ampicillin and 2 more in community-acquired pneumonia (CAP) and pneumonia (13 arms), sponsored by Penta Foundation. Primary endpoints: Hospital readmission or death and Plasma exposure to amoxicillin and clavulanate. Started Oct 2020; status: completed.
02
Drugs
amoxicillinamoxicillin + clavulanatebenzylpenicillingentamicinampicillin
03
Conditions
community-acquired pneumonia (CAP)pneumonia
Beyond the preview
Go deeper on ISRCTN63115131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63115131.